NCT06136819View on ClinicalTrials.gov

RT-310 Dose Escalation BPH Study

PHASE1RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions
BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms
Interventions
COMBINATION_PRODUCT

RT-310

Combination Product: RT-310 Implant for Investigational Treatment of Lower Urinary Tract Symptoms Secondary to BPH (Benign Prostatic Hyperplasia)

Trial Locations (4)

2076

NOT_YET_RECRUITING

Australian Clinical Trials, Wahroonga

3112

RECRUITING

Tauranga Urology Research, Tauranga

3550

RECRUITING

Goldfields Urology, Bendigo

Unknown

RECRUITING

Western Urology, Maribyrnong

All Listed Sponsors
lead

Resurge Therapeutics Inc.

INDUSTRY